23andMe Holding (ME) EV/FCF: History & Chart

23andMe Holding Co. (ME)ME23andMe Holding Co.

About 23andMe Holding Co.

23andMe Holding Co. is a prominent direct-to-consumer genetic testing firm, structured around two primary business units: Consumer & Research Services and Therapeutics. Through its Consumer & Research Services division, the company provides individuals with a comprehensive suite of genetic reports, derived from a simple saliva sample collected via their proprietary kit. These reports offer insights into customers' genetic ancestral origins, predispositions to certain personal health risks, the likelihood of being a carrier for rare conditions that could be passed to offspring, and how their genetic makeup might influence responses to various medications. The Therapeutics segment is dedicated to pharmaceutical research and development, focusing on the discovery and advancement of novel treatments aimed at improving patient well-being across diverse medical fields, including oncology, respiratory, and cardiovascular diseases. This segment also engages in the out-licensing of intellectual property associated with identified drug targets that are progressing through clinical development. 23andMe maintains a strategic partnership with GlaxoSmithKline Intellectual Property (No.3) Limited, leveraging genetic insights to validate, develop, and ultimately commercialize new pharmaceutical products. Established in 2006, the company's corporate headquarters are situated in South San Francisco, California.

South San Francisco, CA

560 employees

www.23andme.org

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Joseph Selsavage

View full financials

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
23andMe Holding Co. (ME)	$15.31M	N/A	N/A	N/A	N/A
NRC Health (NRC)vs ›	$451.75M	23.85x	35.68x	33.50x	32.19x
Shoulder Innovations, Inc. (SI)vs ›	$476.36M	N/A	N/A	N/A	N/A
Teladoc Health, Inc. (TDOC)vs ›	$1.21B	6.50x	7.14x	9.16x	16.42x
DENTSPLY SIRONA Inc. (XRAY)vs ›	$2.81B	46.29x	44.19x	33.47x	28.84x
TransMedics Group, Inc. (TMDX)vs ›	$2.85B	20.95x	96.45x	97.09x	97.09x
Hims & Hers Health, Inc. (HIMS)vs ›	$6.86B	95.62x	90.41x	73.22x	73.22x
Oscar Health, Inc. (OSCR)vs ›	$7.99B	2.12x	2.27x	4.02x	4.27x
Tempus AI, Inc. (TEM)vs ›	$8.20B	N/A	N/A	N/A	N/A
Bio-Rad Laboratories, Inc. (BIO)vs ›	$8.98B	27.00x	25.34x	40.18x	50.79x

NAME

MARKET CAP

EV/FCF RATIO

TTM

23andMe Holding Co. (ME)

$15.31M

N/A

NRC Health (NRC)vs ›

$451.75M

23.85x

35.68x

33.50x